{"downloaded": true, "htmlmade": false, "full": {"id": "32964108", "source": "MED", "pmid": "32964108", "pmcid": "PMC7481221", "fullTextIdList": {"fullTextId": "PMC7481221"}, "doi": "10.1038/s41531-020-00125-y", "title": "Post-GWAS knowledge gap: the how, where, and when.", "authorString": "Pierce SE, Booms A, Prahl J, van der Schans EJC, Tyson T, Coetzee GA.", "authorList": {"author": [{"fullName": "Pierce SE", "firstName": "Steven E", "lastName": "Pierce", "initials": "SE", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI USA."}}}, {"fullName": "Booms A", "firstName": "Alix", "lastName": "Booms", "initials": "A", "authorId": {"@type": "ORCID", "#text": "0000-0001-5907-9313"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI USA."}}}, {"fullName": "Prahl J", "firstName": "Jordan", "lastName": "Prahl", "initials": "J", "authorId": {"@type": "ORCID", "#text": "0000-0002-5088-5981"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI USA."}}}, {"fullName": "van der Schans EJC", "firstName": "Edwin J C", "lastName": "van der Schans", "initials": "EJC", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI USA."}}}, {"fullName": "Tyson T", "firstName": "Trevor", "lastName": "Tyson", "initials": "T", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI USA."}}}, {"fullName": "Coetzee GA", "firstName": "Gerhard A", "lastName": "Coetzee", "initials": "GA", "authorId": {"@type": "ORCID", "#text": "0000-0001-8820-8364"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI USA."}}}]}, "authorIdList": {"authorId": [{"@type": "ORCID", "#text": "0000-0001-5907-9313"}, {"@type": "ORCID", "#text": "0000-0001-8820-8364"}, {"@type": "ORCID", "#text": "0000-0002-5088-5981"}]}, "dataLinksTagsList": {"dataLinkstag": "altmetrics"}, "journalInfo": {"volume": "6", "journalIssueId": "2898987", "dateOfPublication": "2020", "monthOfPublication": "0", "yearOfPublication": "2020", "printPublicationDate": "2020-01-01", "journal": {"title": "NPJ Parkinson's disease", "ISOAbbreviation": "NPJ Parkinsons Dis", "medlineAbbreviation": "NPJ Parkinsons Dis", "NLMid": "101675390", "ISSN": "2373-8057", "ESSN": "2373-8057"}}, "pubYear": "2020", "pageInfo": "23", "abstractText": "Genetic risk for complex diseases very rarely reflects only Mendelian-inherited phenotypes where single-gene mutations can be followed in families by linkage analysis. More commonly, a large set of low-penetrance, small effect-size variants combine to confer risk; they are normally revealed in genome-wide association studies (GWAS), which compare large population groups. Whereas Mendelian inheritance points toward disease mechanisms arising from the mutated genes, in the case of GWAS signals, the effector proteins and even general risk mechanism are mostly unknown. Instead, the utility of GWAS currently lies primarily in predictive and diagnostic information. Although an amazing body of GWAS-based knowledge now exists, we advocate for more funding towards the exploration of the fundamental biology in post-GWAS studies; this research will bring us closer to causality and risk gene identification. Using Parkinson's Disease as an example, we ask, how, where, and when do risk loci contribute to disease?", "affiliation": "Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI USA.", "publicationStatus": "epublish", "language": "eng", "pubModel": "Electronic-eCollection", "pubTypeList": {"pubType": ["review-article", "Review", "Journal Article"]}, "keywordList": {"keyword": ["Genomics", "Neurological Disorders"]}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1038/s41531-020-00125-y"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC7481221"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC7481221?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "0", "hasData": "N", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCreation": "2020-09-23", "firstIndexDate": "2020-09-24", "fullTextReceivedDate": "2020-09-24", "dateOfRevision": "2020-09-28", "electronicPublicationDate": "2020-09-09", "firstPublicationDate": "2020-09-09"}, "htmllinks": "https://europepmc.org/articles/PMC7481221", "abstract": "Genetic risk for complex diseases very rarely reflects only Mendelian-inherited phenotypes where single-gene mutations can be followed in families by linkage analysis. More commonly, a large set of low-penetrance, small effect-size variants combine to confer risk; they are normally revealed in genome-wide association studies (GWAS), which compare large population groups. Whereas Mendelian inheritance points toward disease mechanisms arising from the mutated genes, in the case of GWAS signals, the effector proteins and even general risk mechanism are mostly unknown. Instead, the utility of GWAS currently lies primarily in predictive and diagnostic information. Although an amazing body of GWAS-based knowledge now exists, we advocate for more funding towards the exploration of the fundamental biology in post-GWAS studies; this research will bring us closer to causality and risk gene identification. Using Parkinson's Disease as an example, we ask, how, where, and when do risk loci contribute to disease?", "Keywords": ["Genomics", "Neurological Disorders"], "pdflinks": "https://europepmc.org/articles/PMC7481221?pdf=render", "journaltitle": "NPJ Parkinson's disease", "authorinfo": ["Pierce SE", "Booms A", "Prahl J", "van der Schans EJC", "Tyson T", "Coetzee GA"], "title": "Post-GWAS knowledge gap: the how, where, and when."}